Hirsh J - Search Results

1

The optimal duration of anticoagulant therapy for venous thrombosis.

Hirsh J. Hirsh J. N Engl J Med. 1995 Jun 22;332(25):1710-1. doi: 10.1056/NEJM199506223322510. N Engl J Med. 1995. PMID: 7760874 No abstract available.

2

Heparin therapy in venous thromboembolism.

Hirsh J. Hirsh J. Ann N Y Acad Sci. 1989;556:378-85. doi: 10.1111/j.1749-6632.1989.tb22519.x. Ann N Y Acad Sci. 1989. PMID: 2660687 Review. No abstract available.

3

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA. Kearon C, et al. Among authors: hirsh j. N Engl J Med. 1999 Mar 25;340(12):901-7. doi: 10.1056/NEJM199903253401201. N Engl J Med. 1999. PMID: 10089183 Clinical Trial.

4

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

Levine MN, Gent M, Hirsh J, Arnold A, Goodyear MD, Hryniuk W, De Pauw S. Levine MN, et al. Among authors: hirsh j. N Engl J Med. 1988 Feb 18;318(7):404-7. doi: 10.1056/NEJM198802183180703. N Engl J Med. 1988. PMID: 3340118 Clinical Trial.

5

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.

Turpie AG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrew M, Hull RD, Gent M. Turpie AG, et al. Among authors: hirsh j. N Engl J Med. 1986 Oct 9;315(15):925-9. doi: 10.1056/NEJM198610093151503. N Engl J Med. 1986. PMID: 3531851 Clinical Trial.

6

Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis.

Hirsh J. Hirsh J. N Engl J Med. 1994 Mar 24;330(12):862-3. N Engl J Med. 1994. PMID: 8114845 No abstract available.

7

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time.

Basu D, Gallus A, Hirsh J, Cade J. Basu D, et al. Among authors: hirsh j. N Engl J Med. 1972 Aug 17;287(7):324-7. doi: 10.1056/NEJM197208172870703. N Engl J Med. 1972. PMID: 5041701 No abstract available.

8

Small subcutaneous doses of heparin in prevention of venous thrombosis.

Gallus AS, Hirsh J, Tutle RJ, Trebilcock R, O'Brien SE, Carroll JJ, Minden JH, Hudecki SM. Gallus AS, et al. Among authors: hirsh j. N Engl J Med. 1973 Mar 15;288(11):545-51. doi: 10.1056/NEJM197303152881103. N Engl J Med. 1973. PMID: 4568221 Clinical Trial. No abstract available.

9

Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone.

Kaegi A, Pineo GF, Shimizu A, Trivedi H, Hirsh J, Gent M. Kaegi A, et al. Among authors: hirsh j. N Engl J Med. 1974 Feb 7;290(6):304-6. doi: 10.1056/NEJM197402072900604. N Engl J Med. 1974. PMID: 4588285 Clinical Trial. No abstract available.

10

Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.

Hull R, Delmore T, Carter C, Hirsh J, Genton E, Gent M, Turpie G, McLaughlin D. Hull R, et al. Among authors: hirsh j. N Engl J Med. 1982 Jan 28;306(4):189-94. doi: 10.1056/NEJM198201283060401. N Engl J Med. 1982. PMID: 7033782 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results